C'garh govt says won't use Covaxin till phase 3 trial is over

PTI | Raipur | Updated: 11-02-2021 22:34 IST | Created: 11-02-2021 22:34 IST
C'garh govt says won't use Covaxin till phase 3 trial is over

Chhattisgarh health ministerT S Singh Deo has said that the state government will not usethe indigenously developed Covaxin vaccine against coronavirusuntil its final phase of trials is completed.

He had written a letter to Union Health Minister HarshVardhan, requesting not to send Bharat Biotech's Covaxin tillall trials are over, the minister said on Wednesday.

The Union government has allowed the use of Covishieldvaccine developed by Oxford University and AstraZeneca andCovaxin developed Bharat Biotech for the COVID-19 inoculationprogram in the country.

Singh Deo said Phase-3 trial of Covaxin is notcomplete, and consent forms sent with Covaxin doses, to befilled by the person administering it, underline this fact.

The government can not be expected to complete a trialwhich the company is supposed to do, he said, adding thatthe vaccine would be used in Chhattisgarh once the final phaseof trials is completed successfully.

As per state officials, 66 per cent of 2.74 lakhhealth workers selected for the first phase of inoculationhave received the jab so far.

Chhattisgarh had received about 5.55 lakh doses ofCovishield and over 70,000 doses of Covaxin, but the stategovernment had not given its consent to use Covaxin, officialssaid.

Opposition BJP, meanwhile, accused the Congressgovernment in the state of adopting a stubborn approach overthe use of Covaxin.

Party spokesperson and former minister AjayChandrakar said the state government and Singh Deo weretrying to get political mileage over Covaxin when it is indemand and being used globally.

The Union government allowed the use of Covaxinfollowing all necessary tests, he said.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)


TRENDING

OPINION / BLOG / INTERVIEW

Viral variants and vaccine nationalism pose two-pronged threat to Covid victory

... ...

Tracking Fintech during COVID-19: Harnessing power of technology

Its abundantly clear now that as fintech cements its place in the financial sector, accelerated further by the COVID-19 pandemic, it could open the sector to new possibilities by harnessing the power of technology to deliver financial ...

Tectonic turns: How technology shaped healthcare over the decades

Tracing an episodic evolution, with technology at the interface of human and his health....

World Water Day sees crises of inequality in countries both rich and poor

... ...

Videos

Latest News

Murderer or 'reasonable officer?' Jury begins deliberations in Chauvin trial

Jurors in the murder trial of Derek Chauvin began deliberations on Monday after a prosecutor implored them to believe your eyes as he replayed video of the former Minneapolis police officer kneeling on a dying George Floyds neck. Chauvins l...

Former U.S. Vice President Walter Mondale dies at 93

Walter Mondale, a leading liberal Democratic voice of the late 20th century who was U.S. vice president under Jimmy Carter and lost in a historic landslide to Ronald Reagan in the 1984 presidential election, died on Monday at age 93, his fa...

FOREX-Vaccine hopes boost euro, dollar on back foot as yields off highs

The dollar wallowed near a six-week low against its peers on Tuesday as the euro led a rally on the back of a brightening outlook for the regions vaccination programme.The dollar had already been losing traction as U.S. bond yields have hov...

Former U.S. vice president Walter Mondale dies at 93 -media

Adds details, background. By Will DunhamApril 19 - Walter Mondale, a leading liberal Democratic voice of the late 20th century who was U.S. vice president under Jimmy Carter and lost in a historic landslide to Ronald Reagan in the 1984 pres...

Give Feedback